Arnold & Porter's Antitrust/Competition practice is recognized worldwide for its breadth and depth of experience and its track record of excellence before government enforcers and in the courts. Our strong understanding of the antitrust agencies, frequent dealings with them and deep bench of lawyers with senior government experience in the US and Europe provide us with valuable insight and credibility—key elements for clearing deals and addressing criminal and civil conduct investigations. Our antitrust litigators have extensive experience before judges in jurisdictions favored by the antitrust plaintiff's bar and a record of winning before trial, at trial and on appeal. Because our Antitrust practice regularly handles the full range of complex antitrust matters, our clients benefit from the multiple perspectives brought to each engagement.

Sophisticated Understanding of Global Competition Authorities: Our Antitrust attorneys have held significant senior leadership positions within the FTC, DOJ Antitrust Division and the European Commission.

Strategic Resolution of Complex and Challenging Engagements: Clients come to Arnold & Porter to handle their most complex, challenging transactions and antitrust class action litigation.

Comprehensive Coverage: Our Antitrust team provides solutions for the full range of complex US and EU antitrust issues, including mergers and joint ventures, cartels and other horizontal agreements, exclusionary conduct, agreements with suppliers and distributors, the IP-antitrust interface, and abusive conduct by dominant firms and state aid in the EU.

"Sophisticated antitrust practice which advises and represents clients on large, high-stakes and complex deals, litigation, and investigatory matters... ." —Chambers USA
Arnold & Porter Top Ranked in Chambers USA 2020
"The litigation practice continues to be among the most active... . The firm counselled long-standing clients in some of the largest private actions in the US." —GCR, Global Elite 2020
GCR 100 | 20th Edition

Experience Highlights

  • Abbvie in its $63 billion acquisition of Allergan, the manufacturer of the well-known medication Botox. The Wall Street Journal reported that this was one of the biggest mergers in the healthcare sector in the year it was announced.
  • Bristol-Myers Squibb in its $90 billion acquisition of Celgene and the related $13.4 billion divesture of Celgene's OTEZLA® program to Amgen.
  • AT&T Inc. in its $85.4 billion stock-and-cash acquisition of Time Warner Inc. We successfully defended AT&T in the first vertical merger trial and appeal in decades.
  • Monsanto Company in obtaining US and EU competition clearances in connection with the company's $66 billion acquisition by Bayer, as well as coordinated antitrust/competition approvals in almost 30 other jurisdictions worldwide.
  • Major technology manufacturer in securing the dismissal of an antitrust case that alleged an unlawful employee no-poach agreement and preserving the dismissal on appeal.
  • Golden State Warriors in securing dismissal of antitrust lawsuit challenging the defendants' exclusive partnership for ticket resales. StubHub, Inc. v. Golden State Warriors, LLC and Ticketmaster LLC.
  • Major pharmaceutical company in successfully defending it in putative antitrust class actions alleging that defendants procured patent by fraud and engaged in sham patent litigation. United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund, et al. v. Novartis Pharmaceuticals Corp., et al.
  • HarperCollins Publishers and Penguin Random House in multiple private retailer litigation matters following federal and state government investigations into the sale of eBooks. DNAML PTY, Limited v. Apple, Inc., Abbey House Media Inc. v. Apple Inc., and Diesel Ebooks, LLC v. Apple Inc., et al.
  • General Electric in obtaining antitrust clearance in the US and Europe for the company's €12.35 billion acquisition of Alstom.
  • Visa Inc. in 40 litigation actions, consolidated into MDL 1720, brought by merchants contending that practices relating to so-called "interchange" fees and "no surcharge" rules violate the antitrust law. In re Payment Card Interchange Fee and Merchant Discount Antitrust Litigation.
Subscribe Link

Email Disclaimer